miR-141-3p Is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s171304
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

miR-194 Is a Negative Regulator of GEF-H1 Pathway in Melanoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Myoferlin Is a Key Regulator of EGFR Activity in Breast Cancer

Cancer Research
Cancer ResearchOncology
2013English

miR-195 Is a Key Regulator of Raf1 in Thyroid Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

123 Mir-127–3p as a Novel Regulator of Type I Interferon Signalling Pathway in Sle

2017English

The microRNA miR-8 Is a Conserved Negative Regulator of WNT Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis Through miR-141-3p/PTEN/Akt/mTOR Pathway

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2017English

Comment Re: HMGA2 Is a Negative Regulator of DNA-PK Pathway

Cancer Research
Cancer ResearchOncology
2010English

The Stat3/Socs3a Pathway Is a Key Regulator of Hair Cell Regeneration in Zebrafish Stat3/Socs3a Pathway: Regulator of Hair Cell Regeneration

Journal of Neuroscience
Neuroscience
2012English

Small RNA Sequencing Reveals miR-642a-3p as a Novel Adipocyte-Specific microRNA and miR-30 as a Key Regulator of Human Adipogenesis

Genome Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy